- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 3 x D3J: (2R)-5-[(2-chlorophenyl)sulfanyl]-6'-(4-fluorophenoxy)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro[2,2'-bipyridin]-6(1H)-one(Non-covalent)
D3J.2: 13 residues within 4Å:- Chain A: N.137, P.138, L.164, D.165, R.168, H.192, G.193, D.194, A.237, Y.238, I.241, T.247
- Ligands: NAD.1
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:A.237, A:A.237, A:I.241
- Hydrogen bonds: A:N.137, A:R.168, A:R.168, A:H.192
- pi-Stacking: A:Y.238
D3J.5: 16 residues within 4Å:- Chain B: N.137, P.138, L.164, D.165, R.168, H.192, G.193, D.194, V.233, V.234, A.237, Y.238, I.241, Y.246, T.247
- Ligands: NAD.3
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:N.137, B:A.237, B:I.241
- Hydrogen bonds: B:N.137, B:R.168, B:R.168, B:H.192, B:T.247
- pi-Stacking: B:Y.238
D3J.8: 15 residues within 4Å:- Chain C: R.105, N.137, P.138, L.164, D.165, R.168, H.192, G.193, D.194, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAD.6
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:N.137, C:A.237, C:I.241
- Hydrogen bonds: C:N.137, C:R.168, C:R.168, C:H.192, C:T.247
- pi-Stacking: C:Y.238
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 3 residues within 4Å:- Chain B: W.147, P.153, K.154
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.154
SO4.7: 4 residues within 4Å:- Chain C: W.147, F.152, P.153, K.154
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:K.154
SO4.10: 3 residues within 4Å:- Chain D: W.147, P.153, K.154
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:K.154
- Salt bridges: D:K.154
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam Inhibitors of Human Lactate Dehydrogenase. To Be Published
- Release Date
- 2018-10-24
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 3 x D3J: (2R)-5-[(2-chlorophenyl)sulfanyl]-6'-(4-fluorophenoxy)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro[2,2'-bipyridin]-6(1H)-one(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam Inhibitors of Human Lactate Dehydrogenase. To Be Published
- Release Date
- 2018-10-24
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H